相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signatures
Zhengyan Kan et al.
NATURE COMMUNICATIONS (2018)
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
Eric Pujade-Lauraine et al.
LANCET ONCOLOGY (2017)
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
Mark Robson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Toxicity profile differences of adjuvant docetaxel/cyclophosphamide (TC) between Asian and Caucasian breast cancer patients
L. W. C. Chow et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2017)
Safety and tolerability of the olaparib tablet formulation in Japanese patients with advanced solid tumours
Kan Yonemori et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation
Bella Kaufman et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Breast cancer research in Asia: Adopt or adapt Western knowledge?
Nirmala Bhoo-Pathy et al.
EUROPEAN JOURNAL OF CANCER (2013)
Distribution of BRCA1 and BRCA2 Mutations in Asian Patients with Breast Cancer
Haeyoung Kim et al.
JOURNAL OF BREAST CANCER (2013)
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
Andrew Tutt et al.
LANCET (2010)
Population-based differences in treatment outcome following anticancer drug therapies
Brigette B. Y. Ma et al.
LANCET ONCOLOGY (2010)
Breast cancer as a global health concern
Steven S. Coughlin et al.
CANCER EPIDEMIOLOGY (2009)
Management of HER2-positive breast cancer in Asia: consensus statement from the Asian Oncology Summit 2009
Nan Soon Wong et al.
LANCET ONCOLOGY (2009)
Spectrum of breast cancer in Asian women
Gaurav Agarwal et al.
WORLD JOURNAL OF SURGERY (2007)
分享论文
